http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 GAITHERSBURG, MD - November 4, 2009 - GenVec, Inc. (NASDAQ: GNVC) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to TNFerade(TM) for the... http://pharmalicensing.com/redirs/news_rss/public/news/view/498852/1 http://pharmalicensing.com/redirs/news_rss/public/news/view/498852/1 Paris, France - October 21, 2009 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Wellstat Therapeutics Corporation announced today a global licensing agreement on PN2034, a novel oral... http://pharmalicensing.com/redirs/news_rss/public/news/view/496693/1 http://pharmalicensing.com/redirs/news_rss/public/news/view/496693/1 MATTAWAN, MI October 23, 2009: MPI Research announced that it will be collaborating with Kineta, Inc, a Seattle-based biotechnology company, in advancing their promising autoimmune drug development... http://pharmalicensing.com/redirs/news_rss/public/news/view/496758/1 http://pharmalicensing.com/redirs/news_rss/public/news/view/496758/1 Tokyo, Japan -- October 13, 2009 -- Oncolys BioPharma Inc. (headquarters: Tokyo; President and CEO: Yasuo Urata) announced today that it has entered into a strategic alliance and license agreement... http://pharmalicensing.com/redirs/news_rss/public/news/view/496686/1 http://pharmalicensing.com/redirs/news_rss/public/news/view/496686/1 Milan (Italy), 11 November 2009 - MolMed S.p.A. (Milan:MLM) announces that the European Commission has granted Orphan Drug designation for MolMed's investigational new antitumour therapeutic drug... http://pharmalicensing.com/redirs/news_rss/public/news/view/499722/1 http://pharmalicensing.com/redirs/news_rss/public/news/view/499722/1